🔎 Trials Near Me

Home › Atherosclerosis › Tennessee › Memphis

Atherosclerosis clinical trials in Memphis, TN

7 studies for Atherosclerosis are looking for participants at sites in and around Memphis (within about 30 miles). Open a study to see who can join and how to contact the study team.

A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event

RecruitingPhase 2
  • Olive Branch Family Medical Center, Olive Branch · 18 mi away
Ages 18 and older · All sexes · Updated Sep 30, 2026 · NCT07783802

Clinical Assessment and Targeted Imaging to Characterize High-Risk Atherosclerotic Cardiovascular Disease of Survivors in SJLIFE

RecruitingObservational study
  • St. Jude Children's Research Hospital, Memphis
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT07594392

Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiovascular Disease and Overweight or Obesity

RecruitingPhase 3
  • Stern Cardiovascular Foundation Inc, Germantown · 14 mi away
Ages 45 to 99 · All sexes · Updated Sep 22, 2026 · NCT07037433

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)

RecruitingPhase 2/3
  • Lt. Col. Luke Weathers, Jr. VA Medical Center, Memphis
Ages 18 and older · All sexes · Updated Sep 21, 2026 · NCT05485961

A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event

RecruitingPhase 3
  • Research Site, Memphis
  • Research Site, Memphis
Ages 18 and older · All sexes · Updated Aug 24, 2026 · NCT07000357

Pelacarsen Roll-over Extension Program

RecruitingPhase 3
  • Stern Cardiovascular Foundation Inc, Southaven · 11 mi away
Ages 18 to 100 · All sexes · Updated Jul 29, 2026 · NCT06875973

Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes

RecruitingPhase 4
  • Memphis VA Medical Center, Memphis, TN, Memphis
Ages 18 and older · All sexes · Updated Dec 17, 2025 · NCT02915198

About Atherosclerosis

Atherosclerosis is hardening and narrowing of the arteries caused by the buildup of a fatty substance called plaque. Learn about the risks and prevention.

More about Atherosclerosis on MedlinePlus

Atherosclerosis trials in other cities

Other studies in Memphis

From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.